What is the main business of Stelmed?

The main business activity of Stelmed focuses on specialist medical practice activities.

When was the company founded?

The company was registered in the Polish National Court Register (KRS) on May 13, 2021.

Where is the headquarters located?

The headquarters is located at: ul. Goraszewska 31, 02-910 Warszawa.

Who is on the management board?

The management board consists of: Karolina Stelmaszek (President of the Management Board) and Paweł Stelmaszek (Member of the Management Board).

What is the share capital?

The share capital of the company is PLN 5,000 (approx. $1,351).

What period do the latest financial data cover?

The latest available financial statement covers the period from January 1, 2022 to December 31, 2022.

What revenue was generated?

In 2022, the company's revenue reached $10,396.

No, in 2022 the company was not profitable, reporting a net loss of $118.

What is the main operating cost?

The largest operating cost category falls under other operating costs. This category amounted to $10,048 in 2022, representing 100% of all operating expenses.

Stelmedsp. z o.o.

Specialist medical practice activities

KRS: NIP: REGON:

Overview

Status

Active

Registry date

2021-05-13

Share capital

5,000.00 PLN

Registered address

ul. Goraszewska 31/7, 02-910 Warszawa, Poland

Financials

Revenue history (in k)

Filing timeliness

No financial statement for 2023 – the filing deadline has passed. 2 of 2 financial statements were filed late (the longest delay 431 days for 2021).

2023not filed
202219/09/2023
202119/09/2023

Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2022.

Results vs industry

Revenue

This companyUSD 10.40kMedianUSD 443.52kAverageUSD 1.75m

Net profit

This companyUSD -118.38MedianUSD 14.31kAverageUSD 129.53k

Operating costs

This companyUSD 10.07kMedianUSD 397.10kAverageUSD 1.56m

Assets

This companyUSD 939.03MedianUSD 173.92kAverageUSD 1.02m

Industry

Specialist medical practice activities (86.22.Z)Primary
Sawmilling and planing of wood (16.10)
Manufacture of products of wood, cork, straw and plaiting materials (16.2)

Authorized Representatives

Karolina Stelmaszek – President of the Management Board

Paweł Stelmaszek – Management Board Member

Manner of representation

Each member of the management board is authorized to make declarations on behalf of the company independently.

Ownership

Owner	Shares	Share value	Stake
Karolina Stelmaszekage 38	50	$675.31	50%
Paweł Stelmaszekage 37	50	$675.31	50%

Karolina Stelmaszek and Paweł Stelmaszek hold a combined 100% – the ownership structure indicates family control.

Beneficial owners

Person	Rights

Bank accounts

Registered as a VAT taxpayer on 2023-06-29.

No bank accounts reported to the VAT Taxpayer Register.

Debt

No entries in the National Debtors Register (KRZ).

Public aid

No public aid cases recorded in the last 10 years.

Competitors

Name	Revenue	Website
Nectar Polskasp. z o.o.	$528,123.00	klinikametoda.pl
Astimedsp. z o.o.	$498,540.18	astimed.pl
I. V. Clinicsp. z o.o.	$510,444.80	ivclinic.com.pl
MAAMsp. z o.o.	$455,593.52	urmed.pl
Saska Medsp. z o.o.	$241,826.45	saskamed.pl
Promindsp. z o.o.	$89,181.48	promindclinic.pl
Onkomedicasp. z o.o.	$69,344.55	onkomedica.pl
Biocells Medicalsp. z o.o.	$11,508.17	biocellsmedical.com
Bodyclinicsp. z o.o.	$3,758.46	bodyclinic.pl
Regenerumclinicsp. z o.o.	$1,427.86	regenerumclinic.pl

Change history

Date	Event
2023-12-04	Address change (Ul. Chmielna 2/31, 00-020, Warszawa → Ul. Goraszewska 31/7, 02-910, Warszawa)
2023-12-04	Name change (Le Due Torri → Stelmed)
2023-12-04	PKD change (Removed: 8 codes; Added: 7 codes)
2021-05-13	Entered in the register

FAQ

Last updated: 2026-04-26